General Information
As of 11/25/2009
|
| NAV |
$46.5 |
| NAV Daily Change |
$0.34 |
| % Yield |
0 |
| % SEC Yield |
N/A |
| % YTD Return (as of 10/31/2009) |
14.99 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
17.95 |
| Net Assets (Mil $) 08/31/2009 |
1,074.48 |
| % Turnover 08/31/2009 |
26.71 |
Fees
|
| % Max Sales Load |
5.75 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.25 |
| % Max Management Fee |
.60 |
| % Redemption Fee |
1.00 |
| % Expense Ratio |
1.38 |
Allocation
|
| Large Growth |
31.78 |
| Large Value |
.00 |
| Small Growth |
10.45 |
| Small Value |
.00 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
20.22 |
| Foreign Bond |
.00 |
| High Yield Bond |
.00 |
Portfolio Information |
| Composition |
| As of 08/31/2009 |
% of Net Assets |
| Stock |
96.42 |
| Cash |
.00 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.00 |
| Foreign Stock |
13.99 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
3.58 |
Sector / Country Weightings
|
Sector / Country Weightings
|
| As of 08/31/2009 |
% of Portfolio |
| Health |
65.38 |
| Retail Trade |
10.32 |
| Finance |
9.36 |
| Industrial Cyclical |
8.41 |
| Other |
4.08 |
| Services |
2.08 |
| Technology |
.37 |
| N/A |
N/A |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 08/31/2009) |
% of Portfolio |
Value (Mil$) |
|
| AMGEN INC |
6.94 |
83.26 |
| PFIZER INC |
5.20 |
62.39 |
| GENZYME CORP |
5.04 |
60.50 |
| ROCHE HOLDING AG |
5.02 |
60.22 |
| MEDTRONIC INC |
4.99 |
59.93 |
| ABBOTT LABORATORIES |
4.42 |
53.06 |
| WYETH |
4.22 |
50.72 |
| JOHNSON & JOHNSON |
4.06 |
48.74 |
| HOSPIRA INC |
3.66 |
43.96 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research - NEW!
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now 
|
Fund Description
|
The fund was incepted in May 1982 and is managed by Putnam Investment Management, LLC. The fund seeks capital appreciation. The fund invests in common stocks of companies in the health sciences industries, with a focus on growth stocks. Companies that are fast growing and whose earnings are likely to increase over time issue growth stocks. The fund distributes its dividends and capital gains, if any, annually.
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
08/31/2009 |
| Total Issues |
56 |
| Avg. P/E |
26.82 |
| Avg. P/Book |
5.12 |
| Avg. EPS Growth |
12.36 |
| Avg. Market Value (Mil $) |
43,555 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.63 |
0.63 |
0.49 |
| Alpha |
0.91 |
1.84 |
1.94 |
| R Squared |
0.60 |
0.56 |
0.33 |
| Std. Dev. |
15.77 |
13.25 |
13.98 |
| Sharpe |
-0.38 |
-0.02 |
3.00 |
Shareholder Information
|
| Manager |
Kelsey Chen |
| Since |
01/05 |
| Manager Rating * SEE EXPLANTION |
.2 |
| Inception Date |
05/28/1982 |
| Shareholders |
0 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$500 |
| Minimum Subsequent Investment |
$0 |
| IRA Minimum |
$0 |
| IRA Available |
Y |
Check Writing |
Y |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
Y |
Wire Fee |
Y |
Wire Transfer |
Y |
Contact Information
|
| Family |
Putnam Funds |
| Address |
30 Dan Road
Canton, MA 02021 |
| Phone |
800 225-1581 |
|
Sponsored Links 
